Log in to save to my catalogue

Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection

Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a7a346e0823d4ac4b31cb1856762da34

Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection

About this item

Full title

Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection

Publisher

England: BioMed Central Ltd

Journal title

BMC nephrology, 2025-02, Vol.26 (1), p.71-10

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Relapse of membranous nephropathy (MN) and other glomerular diseases has been observed after COVID-19 infection. The risk factors contributing to disease progression in MN patients after contracting COVID-19 remain unclear.
This retrospective study included 656 consecutive patients with biopsy-proven primary MN who received treatment and were re...

Alternative Titles

Full title

Risk factors for relapse and aggravation in membranous nephropathy after COVID-19 infection

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a7a346e0823d4ac4b31cb1856762da34

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a7a346e0823d4ac4b31cb1856762da34

Other Identifiers

ISSN

1471-2369

E-ISSN

1471-2369

DOI

10.1186/s12882-025-04000-x

How to access this item